All lobbying filings

THEGROUP DC, LLC

THEGROUP DC, LLC filed a Q1 report for ASTELLAS PHARMA US, INC on April 20, 2026, reporting $70,000 in lobbying income.

Lobbying for ASTELLAS PHARMA US, INC · Pharmaceutical research and manufacturing company.

All filings by THEGROUP DC, LLC · Everything ASTELLAS PHARMA US, INC has reported

Filing · LD-2 quarterly report Q1 report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 20, 2026

Income

$70,000

What the client paid this registrant for the period.

Client based in

Illinois

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Health Issues

H.R. 1300, PSA Screening for HIM Act Prostate-Specific Antigen Screening for High-risk Insured Men Act Issues related to the treatment of menopause and womens health at mid-life.

Pharmacy

H.R. 1300, PSA Screening for HIM Act Prostate-Specific Antigen Screening for High-risk Insured Men Act Issues related to the treatment of menopause and womens health at mid-life.

Bills named in this filing 1

H.R. 1300
PSA Screening for HIM Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.